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SUPPLEMENT ARTICLE
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Introduction: Devices for male circumcision (MC) are becoming
available in 14 priority countries where MC is being implemented
for HIV prevention. Understanding potential impact on demand for
services is one important programmatic consideration because
countries determine whether to scale up devices within
MC programs.
Methods: A population-based survey measuring willingness to
undergo MC, assuming availability of surgical MC and 3 devices,
was conducted among 1250 uncircumcised men, ages 10–49 years in
Zambia and 1000 uncircumcised men, ages 13–49 years in
Zimbabwe. Simulated Test Market methodology was used to
estimate incremental MC demand and the extent to which devices
might be preferred over surgery, assuming availability of: surgical
MC in both countries; the devices PrePex, ShangRing, and Unicirc
in Zambia; and PrePex in Zimbabwe.
Results: Modeled estimates indicate PrePex has the potential to
provide an overall increase in MC demand ranging from an
estimated 13%–50%, depending on country and WHO prequaliﬁca-
tion ages, replacing 11%–41% of surgical procedures. In Zambia,
ShangRing could provide 8% overall increase, replacing 45% of
surgical procedures, and Unicirc could provide 30% overall increase,
replacing 85% of surgical procedures.
Conclusions: In both countries, devices have potential to increase
overall demand for MC, assuming wide scale awareness and
availability of circumcision by the devices. With consideration for
age and country, PrePex may provide the greatest potential increase
in demand, followed by Unicirc (measured in Zambia only) and
ShangRing (also Zambia only). These results inform one program
dimension for decision making on potential device introduction
strategies; however, they must be considered within the broader
programmatic context.
Key Words: voluntary medical male circumcision, circumcision,
demand generation, devices, forecast, market research
(J Acquir Immune Deﬁc Syndr 2016;72:S83–S89)
INTRODUCTION
The efﬁcacy of medical male circumcision (MC) in the
reduction of female-to-male HIV transmission has been
demonstrated by observational studies and randomized con-
trolled trials, and MC is recommended for HIV prevention in
countries with high HIV prevalence and low MC preva-
lence.1–5 Although MC programs have been scaling up, the
current uptake of MC is too low to reach the goal of 80% MC
prevalence within the established time frame.
Innovative solutions to simplify the procedure endeavor
to increase acceptability and appeal and decrease implemen-
tation difﬁculties.6 WHO prequaliﬁcation has been granted
for 2 devices for adolescent and adult circumcision, PrePex
and ShangRing.7,8 A third, Unicirc, is in clinical development.
PrePex is an elastic collar compression device, consisting of
a rigid inner ring and an elastic outer ring that restrict blood
ﬂow resulting in ischemia and necrosis of the foreskin; it does
not require a sterile ﬁeld or injected anesthesia. ShangRing is
a collar clamp device, consisting of 2 concentric plastic rings
that provide tight compression to achieve hemostasis, at
which time the live foreskin tissue is removed. A sterile ﬁeld
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and injected anesthesia are required. For both of these
devices, a follow-up visit is required for device removal
and healing is 1–2 weeks longer than for surgery.9 Despite
this, both have been shown to achieve higher client satisfac-
tion from a cosmetic point of view compared with sur-
gery.10,11 Unicirc is a clamp that applies tight compression to
achieve hemostasis and tissue sealing. After excision of the
foreskin, tissue adhesive is used to close the wound, and the
device is removed at the same visit, thus no follow-up visit is
required for removal. A sterile ﬁeld is required; however, the
procedure does not require injected anesthesia.12 In trials,
medical eligibility and rates of successful circumcision were
adequate for both PrePex and ShangRing (sufﬁcient data for
Unicirc are not available). Rates of adverse events for PrePex
and ShangRing are comparable to surgery.13,14 All 3 devices
require a shorter procedure time than surgery (including
application and removal) and no sutures.
The incorporation of these devices into MC programs
may lead to increases in MC uptake and/or replacement of the
existing surgical service. Incremental demand is deﬁned as
the increase in circumcisions performed if a device was
available in addition to surgery that could extend circumci-
sion to those who would otherwise remain uncircumcised.
Replacement is deﬁned as the number of circumcisions
performed with a device that would otherwise have been
performed surgically, if only surgery were available. Replace-
ment may be beneﬁcial if device-based methods are easier or
more affordable and harmful if cost savings and/or service
improvements are negligible and insufﬁcient to offset device
training and logistical costs. Estimating the potential incre-
mental demand and/or replacement by devices is essential to
inform decisions on device implementation.
MC is part of the national HIV prevention strategy in
Zambia and Zimbabwe.15,16 In 2014, we conducted primary
research to assess whether device incorporation into MC
programs would generate incremental demand and the extent
to which devices could replace surgery. Despite increasing
levels of circumcision in both countries, resulting in 32.6% of
the country goal in Zambia and 10.6% in Zimbabwe by
2013,17 a dramatic increase in scale-up of MC is needed.
Several supply-side factors, such as shortages of trained
providers, infrastructure, and transportation capacity for out-
reach, contribute to low target achievement.18 Another critical
contributing factor is low demand for MC.19 Although there is
evidence on the safety and acceptability of devices, and the
potential of devices to increase efﬁciencies,20 there are no
systematic primary data on client preferences and whether
alternatives in circumcision methods could increase demand.
METHODS
Study Sample and Data Collection
Data were collected through a structured, quantitative
survey in each country in 2014. Survey samples consisted of
uncircumcised men in the age range aligned to the national
policy for MC. Districts in each country with the most
uncircumcised men were chosen, cumulatively accounting for
80% of the goal deﬁned by the national MC strategies, (38 of
72 districts in Zambia, and 35 of 61 districts in Zimbabwe).
Samples were distributed by age in proportion to the
population size for each age group in each district. In selected
districts, households were randomly sampled and 1 man per
household was approached. If more than 1 eligible man
resided in the household, selection was made through using
a preassigned table of random numbers.21 Once a quota for an
age group was reached in a district, only men who met open
quota criteria were interviewed. If the household’s selected
man was not available or ineligible, the next household was
approached. Refusal rates (4.7% in Zambia and 4.9% in
Zimbabwe) were low and in line with similar research and
most were due to not having time to participate. Participants
were interviewed face-to-face and a mobile phone-based data
collection platform was used to automate questionnaire logic,
MC procedure proﬁle randomization, sample quota manage-
ment, and data collection.
In each country, the sample was split into 2 arms. The
Surgery-only Arm (n = 257 in Zambia, n = 333 in Zimbabwe)
provided an estimation of the potential increase in MC
demand resulting from receiving complete information pro-
vided on the existing surgical service, unbiased by exposure
to device procedure proﬁles. The Surgery and Devices Arm
(n = 993 in Zambia, n = 667 in Zimbabwe) provided an
estimation of the potential increase in MC demand and/or
replacement generated by availability of devices as alternative
procedure to surgery (Fig. 1).
For each arm, the questionnaire included 5 sequential
sections: (1) ratings of agreement with statements describing
attitudes and perceptions about MC using a 7-point scale and
measurement of willingness to undergo MC using a 5-point scale
for baseline and each subsequent postexposure measure of
willingness to be circumcised; (2) exposure to general MC
information, beneﬁts, risks and procedure process (agnostic of
procedure type), and postexposure willingness to undergo MC;
(3) exposure to “short” proﬁle(s) for procedure type (surgery only
in the Surgery-only Arm or randomized order of surgery and
each device proﬁle in the Surgery and Devices Arm) and
postexposure willingness to be circumcised, including rating each
of the procedures after exposure to all procedure short proﬁles;
(4) exposure to “long” proﬁle(s) and postexposure willingness to
be circumcised (as outlined above for the short proﬁles); and, (5)
postexposure ratings of agreement with statements describing
attitudes and perceptions about circumcision.
The general information provided on MC was reﬂective
of the information an interpersonal communicator would
share, agnostic of procedure type. The “short” proﬁles were
reﬂective of information an interpersonal communicator
would share about each MC procedure type and measures
of postexposure willingness to be circumcised were used to
estimate the proportion of men going to clinics to receive MC
through surgery or one of the devices. The “long” proﬁles
reﬂected information given in a clinic counseling session
before circumcision and measures of postexposure willing-
ness to be circumcised were used to estimate switching of
preferred circumcision methods “at the clinic”, once full
counseling information is provided.
The proﬁles for surgery and PrePex were developed
from existing materials in use by MC programs. Because
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ShangRing and Unicirc are not yet routinely in use, the
proﬁles were developed in consultation with stakeholders
experienced using these devices and development of demand
and counseling materials. With all 3 devices, proﬁles assumed
use of topical rather than injected anesthesia. Although the
WHO prequaliﬁcation for ShangRing requires injectable
anesthesia, the proﬁle used topical anesthesia because
this is being used successfully with ShangRing in China
and is being studied in Kenya (personal oral communication,
January 2016, Mark Barone, DVM).
Zambian participants viewed proﬁles for surgery, as
well as the PrePex, ShangRing, and Unicirc procedures.
Participants in Zimbabwe viewed proﬁles for surgery and
PrePex. Eligible boys younger than 18 years were interviewed
with their parents/guardians for ethical reasons and to capture
the “decision dynamic” between the boy and parent/guardian.
All parents/guardians provided informed consent and boys
assented to participate.
Analytical Approach
A simulated test market (STM) model (Fig. 2) was used
to measure incremental demand generated by complete
information for surgery and by PrePex, ShangRing, and
Unicirc devices (by country), as well as the extent of
replacement of surgery by each device. The model was
designed to simulate the MC experience, from becoming
aware of MC as a way to prevent HIV and other infections to
the ﬁnal outcome of completing the procedure.
STM models were developed in the 1970s to provide
information about new products or services, measure willing-
ness to purchase products or services after exposure(s) to
information and accurately convert consumer responses into
purchase probabilities. STM models have been used to forecast
new product demand for consumer packaged goods, pharma-
ceuticals, and medical devices. In developed markets, STM
techniques report validation of 610% of the forecast 90% of
the time.22,23 In developing markets, it is not possible to
quantify accuracy/uncertainty because the assumptions are
based on the market researchers’ experience-informed opin-
ions, and CIs around point estimates cannot be provided.
The STM model to measure demand relies on “will-
ingness to be circumcised” questions to determine uptake.
Respondents used a ﬁve-point scale to answer: considering
what you have just seen, which statement best describes how
willing you would be to undergo circumcision using this
procedure, if the service would be free to you? Deﬁnitely
Would, Probably Would, May or May Not, Probably Would
Not, and Deﬁnitely Would Not.24,25
STM models remove respondent overstatement by
applying lessons from studies comparing stated and actual
consumer behavior and through mathematical modeling.
Overstatement factors were developed from longitudinal
studies comparing responses to actual uptake for products
and medical treatments and from analysis of country program
MC data. Weighted overstatement factors were applied to
determine the probability of actual uptake if the MC pro-
cedure in question were available.
FIGURE 1. MC device forecast
questionnaire consort flow diagram.
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To limit order bias where multiple proﬁles are tested,
only the ﬁrst and second exposures to proﬁles are used to
estimate demand. Responses from participants, who saw
surgery followed by PrePex, or PrePex followed by surgery,
are used to estimate surgery and PrePex uptake for scenarios
where surgery and PrePex are the only available circumcision
methods. Similarly, only response data for respondents who
saw surgery followed by ShangRing, or ShangRing followed
by surgery, as the ﬁrst and second proﬁles are used to estimate
surgery and ShangRing uptake for scenarios where surgery
and ShangRing are the only available circumcision methods,
etc. The ﬁrst- and second-order sample sizes for each
procedure combination in each country were as follows:
Zambia—surgery and PrePex (n = 162), surgery and
ShangRing (n = 170), and surgery and Unicirc (n = 172);
Zimbabwe—surgery and PrePex (n= 666).
MC uptake in each country during 2014 was used for
baseline MC volumes. Potential incremental demand and/or
replacement were estimated for: (1) complete information for
surgery-only (Zambia and Zimbabwe); (2) surgery + PrePex
(Zambia and Zimbabwe); (3) surgery + ShangRing (Zambia);
and, (4) surgery + Unicirc (Zambia). Awareness of the
beneﬁts and risks for surgery and each device and availability
of surgery, PrePex, ShangRing, and Unicirc were assumed to
be equivalent to that for surgery in 2014. The proportion of
aware, motivated men considering MC within the target
populations in Zambia and Zimbabwe was derived from the
level of awareness determined by questionnaire responses.
The medical eligibility rate for Unicirc and ShangRing was
assumed to be a 99%; for PrePex it was assumed to be 90%
for men aged 18+, and 64% for boys aged 13–17.26 Although
they were included in the survey sample for Zambia,
projections of incremental demand for all MC devices
excluded boys aged 10–12 due to the lack of data on medical
eligibility and potential WHO prequaliﬁcation for this
age group.
Potential barriers to MC service delivery, such as
introduction, distribution, stocking, availability of trained
providers, and coordination of services with demand were
assumed to be equivalent to levels for surgical MC in 2014.
Although modeling the effect of a gradual scale up of demand
generation and supply on device uptake would provide a more
realistic assessment of the impact of devices on MC demand,
this approach was not completed because plans and support
for the introduction and integration of devices were unknown.
RESULTS
Potential for Devices in Scale-Up of
MC, Zambia
In Zambia, providing complete information on the
surgical procedure could provide an estimated 5% increase
in demand for MCs (Table 1). With awareness and service
availability equal to surgery in 2014, PrePex could have
increased the total number of MCs by 23% for those aged 18–
49. Of the total surgical procedures performed in 2014, our
model estimates that 20% would have been replaced using
FIGURE 2. The MC STM model.
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PrePex. With WHO prequaliﬁcation of PrePex for 13–17 year
olds, modeling suggests it could have produced an estimated
41% incremental demand for MCs, while replacing an
estimated 36% of existing surgical procedures. Assuming
WHO prequaliﬁcation for 13–17 year olds and wide avail-
ability in 2014, Unicirc could have created a 30% incremental
increase, with 85% replacement, whereas ShangRing could
have created an 8% increase, with 45% replacement of
surgeries. Preferences among the 4 procedure types did not
vary signiﬁcantly by age group (Table 3).
Potential for Devices in Scale-Up of
MC, Zimbabwe
In Zimbabwe, complete information for the surgical
procedure generated an estimated 4% incremental increase in
modeled MC demand (Table 1). Modeled demand for PrePex
resulted in an estimated 13% incremental increase in demand,
while replacing 11% of surgeries for those aged 18–29.
Including 13–17 year olds, PrePex could have created an
estimated 50% incremental increase in MC demand, with an
estimated 41% replacement of the 2014 surgical procedures.
PrePex was the preferred MC option for all age groups with
strongest support among men aged 15–19 (Table 4).
Differential Procedure Preferences
Among Men
In both countries, men who prefer surgery are more
likely to have a relatively strong commitment to circumcision
and communicate less fear of surgical procedures, injections,
and anticipated pain of surgery than men who prefer PrePex,
who are more likely to communicate greater concerns about
surgery, injections, and fear of pain from the procedure (Table
2). Alternatively, the Unicirc and ShangRing procedures are
preferred by many who would have opted for surgical MC,
leading to heavy estimated replacement of the existing
surgical service in Zambia of 85% and 45% for Unicirc and
ShangRing, respectively. Responses and preferences and
willingness to become circumcised after presentation of long
proﬁles did not signiﬁcantly differ to those given after the
short proﬁles indicating that there was no evidence that there
would be change of preference “at the clinic”, once full
counseling information is provided.
TABLE 1. Incremental % Increase Demand vs. % Surgeries Replaced, by Device
Base (Denominator for % Δ) Scenario
Zambia Zimbabwe
Incremental % Increase
in MC Demand
% Surgeries
Replaced
Incremental % Increase
in MC Demand
% Surgeries
Replaced
Among total eligible: ages 10–49
in Zambia; ages 13–49 in
Zimbabwe
Surgery + complete information on
surgical procedure
5 0 4 0
Surgery + PrePex (18–49 yrs) 23* 20† 13* 11†
Surgery + PrePex (13–49 yrs) 41* 36† 50* 41†
Surgery + ShangRing (13–49 yrs) 8 45 — —
Surgery + Unicirc (13–49 yrs) 30 85 — —
Among ages 18+ in each
country
Surgery + PrePex (18–49 yrs) 46 40 37 32
Surgery + Shang Ring (18–49 yrs) 8 43 — —
Surgery + Unicirc (18–49 yrs) 33 87 — —
Among ages 13–17 in each
country
Surgery + PrePex (13–17 yrs) 36 31 57 58
Surgery + Shang Ring (13–17 yrs) 9 46 — —
Surgery + Unicirc (13–17) 28 83 — —
*Estimated new MCs which would not have happened under surgery-only scenario/base.
†Estimated MCs that would have happened through surgery, but for which device availability would replace/base.
TABLE 2. Preferred MC Procedure Type by Age for Zambia
Zambia
Sample Size, n Prefer Surgical VMMC, % Prefer PrePex, % Prefer ShangRing, % Prefer Unicirc, %
All ages (10–49) 992 25 35 16 23
10–14 261 26 36 16 23
15–19 200 23 37 19 23
20–24 160 24 37 18 22
25–29 123 33 34 14 20
30–49 248 23 33 16 27
P 0.407 0.944 0.830 0.710
VMMC, Voluntary Medical Male Circumcision.
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Limitations
The fundamental limitation of this model is that it
presents a best-case scenario, which is likely unrealistic but
can still be used as important input for decision making.
Since the start of their MC programs, both countries
achieved the highest levels of uptake for surgical MC in
2014. By assuming that awareness, promotion, and service
for each device and surgical MC will continue at peak levels
without a similar scale-up period for the selected device(s),
we present an environment that is theoretical and unrealistic
in the immediate term, but describes potential for the long
term, after scale-up of devices. Because achieving this
scenario would require high levels of program funding,
training, and organizational efﬁciencies, achieving the
modeled levels of demand for these devices would take
time, stakeholder commitments, long-term investment, and
robust program analysis.
CONCLUSIONS
This research ﬁnds that introduction of devices can
stimulate additional demand for MC, particularly among
men and boys who are concerned about and fear the surgical
procedure. PrePex has appeal to men who have these
concerns and likely explains the highest incremental demand
in each country for PrePex, with limited replacement of
existing surgical service. If PrePex receives WHO pre-
qualiﬁcation for 13–17 year olds, this incremental demand
increases. Although uptake for adolescents is already high,
most are not yet circumcised in most of the priority
countries. ShangRing and Unicirc appeal to boys and men
who are also receptive to surgical MC, which, when coupled
with the high medical eligibility rates for these devices,
results in higher replacement rates for surgical MC relative
TABLE 4. Preferred MC Procedure Type by Age for Zimbabwe
Zimbabwe
Sample
Size, n
Prefer Surgical
VMMC, %
Prefer
PrePex, %
All ages (13–49) 661 30 70
13–14 67 31 69
15–19 133 23 77
20–24 109 38 62
25–29 100 31 69
30–49 252 31 69
P 0.344 0.740
VMMC, Voluntary Medical Male Circumcision.
TABLE 3. Perceptual Differences of MC by Procedure Method Preference (Boys and Men Preferring Surgery vs. Boys and Men
Preferring PrePex)
Zimbabwe (n = 661) Zambia (n = 598)
Those Who
Preferred
Surgery, %
Those Who
Preferred
PrePex, %
Signiﬁcance,
P
Those Who
Preferred
Surgery, %
Those Who
Preferred
PrePex, %
Signiﬁcance,
P
Sample size, n 200* 461* 249† 349†
Commitment to VMMC 68 52 0.0001 60 55 0.2255
% of respondents who gave top-2 rating of agreement with statements (TOP-2 rating on 7-point Likert scale where 1 means “strongly disagree”, 4 means “neither
agree nor disagree”, and 7 means “strongly agree”)
Having a surgery would make me
nervous
34 45 0.0084 34 48 0.0006
I do not like to get injections with
a needle; I avoid them
whenever possible
21 32 0.0041 32 36 0.3099
The circumcision procedure is
very painful
41 52 0.0093 39 39 0.9999
The beneﬁts from MC are worth
the risks
64 53 0.0088 49 48 0.8084
% of respondents who gave bottom-2 rating of agreement with statements (bottom-2 rating on 7-point Likert scale where 1 means “strongly disagree”, 4 means
“neither agree nor disagree”, and 7 means “strongly agree”)
Healing after circumcision is very
painful
16 15 0.7429 23 16 0.0312
The healing time after
circumcision is too long
29 22 0.0533 34 22 0.0011
The time off from work or school
after circumcision is too long
40 32 0.0467 33 26 0.0627
VMMC, Voluntary Medical Male Circumcision.
*In Zimbabwe, 667 respondents were exposed to the device proﬁle. Of those 667 men, 200 preferred surgical MC, 461 preferred PrePex, and 6 had no preference; thus, the table
comparing surgery vs. PrePex has total sample of n = 661.
†In Zambia, a total of 993 men were exposed to the device proﬁles. Of those 993 men, 249 preferred surgery, 349 preferred PrePex, and 395 respondents preferred ShangRing (n =
164), Unicirc (n = 230), or had no preference (n = 1); thus, the table comparing surgery vs. PrePex has total sample of n = 598.
Fram et al J Acquir Immune Defic Syndr  Volume 72, Supplement 1, June 1, 2016
S88 | www.jaids.com Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
to incremental demand. Unicirc is preferred to surgery and
does generate substantial incremental demand, so it may
provide for a long-term replacement of the surgical pro-
cedure, if cost of introduction and other factors affecting
scale up are acceptable.
Integration of devices into existing programs is not
seamless and will require consideration of many program-
matic factors, including training of providers, quantiﬁcation
of need and distribution of multiple sizes, other costs of
introduction, waste management, surgical backup, and refer-
rals. Managing program services for 2 procedure types may be
more complex to administer and coordinate and potentially
costlier than managing a single service program. This could
impact program efﬁciency and outweigh savings in delivery
costs, at least during initial integration phases. Given the
relatively high rate of ineligibility for PrePex among 13–17
year olds, the age group for which MC uptake is highest,
surgery will always be a needed alternative with this approach,
unless, for example, Unicirc proves to have equivalent medical
eligibility rates as surgery and other factors warrant it replacing
surgery. Within the current funding environment for MC
programs globally, countries need robust evaluation of all
factors, including potential impact on demand as modeled here,
to make a data-driven decision on device introduction.
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